Pacific Biosciences of California(PACB) - 2024 Q1 - Earnings Call Transcript

Operator And it seems like you've kind of veered now to the former cutting cost. But that ultimately hurts your ability to kind of scale up to be a bigger company. And there's a toggle between those things, right? And what I don't hear is kind of a pruning of the portfolio. So I'm trying to figure out how do you cut costs and how do we balance that. We want you to do that, but if you're cutting costs and you're not pruning the portfolio, simply put, it kind of feels like you're still trying to thread the ne ...